Immunophenotypic and genotypic features, clinical characteristics and treatment outcome of adult pro-B acute lymphoblastic leukemia: Results of the German multicenter trials GMALL 03/87 and 04/89

Blood

Volumn 92, Issue 6, 1998, Pages 1898-1909

  Ludwig, Wolf Dieter ^a   Rieder, Harald ^b   Bartram, Claus R ^b   Heinze, Barbara ^b   Schwartz, Stefan ^b   Gassmann, Winfried ^b   Löffler, Helmut ^b   Hossfeld, Dieter ^b   Heil, Gerhard ^b   Handt, Susanne ^b   Heyll, Axel ^b   Diedrich, Helmut ^b   Fischer, Konstanze ^b   Weiss, Adelheid ^b   Völkers, Bernd ^b   Aydemir, Ülker ^b   Fonatsch, Christa ^b   Gökbuget, Nicola ^b   Thiel, Eckhard ^b   Hoelzer, Dieter ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; TENIPOSIDE; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CHROMOSOME 11Q; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION 4; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE REARRANGEMENT; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; FEMALE; HUMANS; IMMUNOPHENOTYPING; KARYOTYPING; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; LEUKEMIA, PRE-B-CELL; MALE; MIDDLE AGED; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 0032530350     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Cline MJ: The molecular basis of leukemia. N Engl J Med 330:328, 1994
2. Ludwig WD, Raghavachar A, Thiel E: Immunophenotypic classification of acute lymphoblastic leukemia. Clin Haematol 7:235, 1994
3. Pui CH: Childhood leukemias. N Engl J Med 332:1618, 1995
4. Hoelzer DF: Therapy of the newly diagnosed adult with acute lymphoblastic leukemia. Hematol Oncol Clin North Am 7:139, 1993
5. Copelan EA, McGuire EA: The biology and treatment of acute lymphoblastic leukemia in adults. Blood 85:1151, 1995
6. Raimondi SC: Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 81:2237, 1993
7. Hoelzer D, Thiel E, Löffler H, Büchner Th, Ganser A. Heil G, Koch P, Freund M, Diedrich H, Rühl D, Maschmeyer G, Lipp T, Nowrousian MR, Burkert M, Gerecke D, Pralle H, Müller U, Lunscken Ch. Fülle H, Ho AD, Küchler R, Busch FW, Schneider W, Görg Ch, Emmerich B, Braumann D, Vaupel HA, von Paleske A, Bartels H, Neiss A, Messerer D: Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 71:123, 1988
8. Janossy G, Coustan-Smith E, Campana D: The reliability of cytoplasmic CD3 and CD22 antigen expression in the immundiagnosis of acute leukemia: A study of 500 cases. Leukemia 3:170, 1989
9. Garand R, Vannier JP, Béné MC, Faure GC, Bernard A: Correlations between acute lymphoid leukemia (ALL) immunophenotype and clinical and laboratory data at presentation. A study of 350 patients. Cancer 64:1437, 1989
10. Van't Veer MB, van Putten WLJ, Verdonck LF, Ossenkoppele GJ, Löwenberg B, Kluin-Nelemans JC, Wijermans PW, Schouten HC, Sizoo W, Dekker AW: Acute lymphoblastic leukaemia in adults: Immunological subtypes and clinical features at presentation. Ann Hematol 66:277, 1993
11. De Rossi G, Grossi C, Foà R, Tabilio A, Vegna L, Lo Coco F, Annino L, Camera A, Cascavilla N, Ciolli S, Del Poeta G, Liso V, Mandelli F: Immunophenotype of acute lymphoblastic leukemia cells: The experience of the Italian Cooperative Group (Gimema). Leukemia 9:221, 1993
12. Ludwig WD, Reiter A. Löffler H, Gökbuget N, Hoelzer D, Riehm H, Thiel E: Immunophenotypic features of childhood and adult acute lymphoblastic leukemia (ALL): Experience of the German multicentre trials ALL-BFM and GMALL. Leuk Lymphoma 13:71, 1994(suppl 1)
13. Boucheix C, David B, Sebban C, Racadot E, Béné MC, Bernard A, Campos L, Jouault H, Sigaux F, Lepage E. Hervé P, Fiére D: Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: An analysis of a prospective trial including 562 tested patients (LALA87). Blood 84:1603, 1994
14. European Group for the Immunological Characterization of Leukemias (EGIL): Béné MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB: Proposals for the immunological classification of acute leukemias. Leukemia 9:1783, 1995
15. The Groupe Francais de Cytogénétique Hématologique: Cytogenetic abnormalities in adult acute lymphoblastic leukemia: Correlations with hématologic findings and outcome. A collaborative study of the Groupe Francais de Cytogénétique Hématologique. Blood 87:3135, 1996
16. Pui CH, Williams DL, Raimondi SC, Melvin SL, Behm FG, Look AT, Dahl GV, Rivera GK, Kalwinsky DK, Mirro J, Dodge RK, Murphy SB: Unfavorable presenting clinical and laboratory features are associated with CALLA-negative non-T, non-B lymphoblastic leukemia in children. Leukemia 10:1287, 1986
17. Pui CH, Rivera GK, Hancock ML, Raimondi SC, Sandlund JT, Mahmoud HH, Ribeiro RC, Furman WL, Hurwitz CA, Crist WM, Behm FG: Clinical significance of CD10 expression in childhood acute lymphoblastic leukemia. Leukemia 7:35, 1993
18. Ludwig WD, Bartram CR, Harbott J, Koller U, Haas OA, Hansen-Hagge T, Heil G, Seibt-Jung H, Teichmann JV, Ritter J, Knapp W, Gadner H, Thiel E, Riehm J: Phenotypic and genotypic heterogeneity in infant acute leukemia I. Acute lymphoblastic leukemia. Leukemia 3:431, 1989
19. Pui CH, Frankel LS, Carroll AJ, Raimondi SC, Shuster JJ, Head DR, Crist WM, Land VJ, Pullen DJ, Steuber CP, Behm FG, Borowitz MJ: Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11) (q21;q23): A collaborative study of 40 cases. Blood 77:440, 1991
20. Reiter A, Schrappe M, Ludwig WD, Hiddemann W, Sauter S, Henze G, Zimmermann M, Lampert F, Havers W, Niethammer D, Odenwald E, Ritter J, Mann G, Weite K, Gadner H, Riehm H: Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 84:3122, 1994
21. Pui CH, Kane JR, Crist WM: Biology and treatment of infant leukemias. Leukemia 9:762, 1995
22. Rubnitz JE, Behm FG, Downing JR: 11q23 rearrangements in acute leukemia. Leukemia 10:74, 1996
23. Ziemin-van der Poel S, McCabe NR, Gill HJ, Espinosa R III, Patel Y, Harden A, Rubinelli P, Smith SD, LeBeau MM, Rowley JD, Diaz MO: Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci USA 88:10735, 1991
24. Cimino G, Moir DT, Canaani O, Williams K, Crist WM, Katzav S, Cannizzaro L, Lange B, Nowell PC, Croce CM, Canaani E: Cloning of ALL-1, the locus involved in leukemias with the t(4;11) (q21;q23), t(9;11) (q22:q23), and t(11;19) (q23;p13) chromosome translocations. Cancer Res 51:6712, 1991
25. Thirman MJ, Gill HJ, Burnett RC, Mbangkollo D, McCabe NR, Kobayashi H, Ziemin-van-der-Poel S, Kaneko Y, Morgan R, Sandberg AA, Chaganti RSK, Larson RA, LeBeau MM, Diaz MO, Rowley JD: Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal trans locations. Leukemia 329:909, 1993
26. Corral J, Forster A, Thompson S, Lampert F, Kaneko Y, Slater R, Kroes WG, van der School CE, Ludwig WD, Karpas A, Pocock C, Cotter F, Rabbitts TH: Acute leukaemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation. Proc Natl Acad Sci USA 90:8538, 1993
27. Mbangkollo D, Burnett R, McCabe N, Thirman M, Gill H, Yu H, Rowley JD, Diaz MO: The human MLL gene: Nucleotide sequence, homology to the Drosophila trx zinc-finger domain, and alternative splicing. DNA Cell Biol 14:475, 1995
28. Léglise MC, Rivière D, Brière J: Acute leukemia with a translocation t(4;11)(q21;q23): A distinct clinicopathological entity. Leuk Lymphoma 2:353, 1990
29. Pui CH: Acute leukemias with the t(4;11)(q21;q23). Leuk Lymphoma 7:173, 1992
30. Hilden JM, Kersey JH: The MLL (11q23) and AF-4 (4q21) genes disrupted in t(4;11) acute leukemia: Molecular and clinical studies. Leukemia 14:189, 1994
31. Bloomfield CD, Seeker-Walker L, Goldman LM, Van den Berghe H, de la Chapelle A, Ruutu T, Alimena G, Garson OM, Golomb HM, Rowley JD, Kaneko Y, Whang-Peng J, Prigogina E, Philip P, Sandberg AA, Lawler SD, Mitelman F: Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia. Cancer Genet Cytogenet 40:171, 1989
32. Hagemeijer A, van der Plas DC: Clinical relevance of cytogenetics in acute leukemia. Hematol Blood Transfus 33:23, 1990
33. Rieder H, Ludwig WD, Gassmann W, Thiel E, Löffler H, Hoelzer D, Fonatsch C: Chromosomal abnormalities in adult acute lymphoblastic leukemia: Results of the German ALL/AUL study group. Recent Results Cancer Res 131:133, 1993
34. Pui CH, Carrol AJ, Raimondi SC, Shuster JJ, Crist WM, Pullen DJ: Childhood acute lymphoblastic leukemia with thet(4;11)(q21;q23): An update. Blood 83:2384, 1994
35. Mirro J, Kitchingman G, Williams D, Lauzon GJ, Lin CC, Callihan T, Zipf TF: Clinical and laboratory characteristics of acute leukemia with the 4;11 translocation. Blood 67:689, 1986
36. Hagemeijer A, van Dongen JM, Slater RM, van't Veer MB, Behrendt H, Hählen K, Sizoo W, Abels J: Characterization of the blast cells in acute leukemia with translocation (4;11): Report of eight additional cases and of one case with a variant translocation. Leukemia 1:24, 1987
37. Lampert F, Harbott J, Ludwig WD, Bartram CR, Ritter J, Gerein V, Neidhardt M, Mertens R, Graf N, Riehm H: Acute leukemia with chromosome translocation (4;11): 7 new patients and analysis of 71 cases. Blut 54:325, 1987
38. Drexler HG, Thiel E, Ludwig WD: Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. Leukemia 5:637, 1991
39. Chen CS, Sorensen PHB, Domer PH, Reaman GH, Korsmeyer SJ, Heerema NA, Hammond GD, Kersey JH: Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. Blood 81:2386, 1993
40. Rubnitz JE, Link MP, Shuster JJ, Carroll AJ, Hakami N, Frankel LS, Pullen DJ, Cleary ML: Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: A Pediatrie Oncology Group study. Blood 84:570, 1994
41. Behm FG, Raimondi SC, Frestedt JL, Liu Q, Crist WM, Downing JR, Rivera GK, Kersey JH, Pui CH: Rearrangements of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age. Blood 87:2870, 1996
42. Seeker-Walker LM, Craig JM, Hawkins JM, Hoffbrand AV: Philadelphia positive acute lymphoblastic leukemia in adults: Age distribution. BCR breakpoint and prognostic significance. Leukemia 5:196, 1991
43. Schardt C, Ottmann OG, Hoelzer D, Ganser A: Acute lymhoblastic leukemia with the t(4;11) translocation: Combined cytogenetic, immunological and molecular genetic analyses. Leukemia 6:370, 1992
44. Stock W, Thirman MJ, Dodge RK, Rowley JD, Diaz MO, Wurster-Hill D, Sobol RE, Davey FR, Larson RA, Westbrook CA, Bloomfield CD: Detection of MLL gene rearrangements in adult acute lymphoblastic leukemia. A Cancer and Leukemia Group B study. Leukemia 8:1918, 1994
45. Larson RA, Dodge RK. Burns CP, Lee EJ, Stone RM, Schulman P, Duggan D, Davey FR, Sobol RE, Frankel SR, Hooberman AL, Westbrook CA, Arthur DC, George SL, Bloomfield CD, Schiffer CA: A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 8811. Blood 85:2025, 1995
46. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C: Proposals for the classification of the acute Jeukemias. French-American-British (FAB) Co-operative Group. Br J Haematol 33:451, 1976
47. Creutzig U, Harbott J, Sperling C, Ritter J, Zimmermann M, Löffler H, Riehm H, Schellong G, Ludwig WD: Clinical significance of surface antigen expression in children with acute myeloid leukemia: Results of study AML-BFM-87. Blood 86:3097, 1995
48. ISCN: An International System for Human Cytogenetic Nomenclature. Basel. Switzerland, Karger, 1985
49. Janssen JWG, Ludwig WD, Borkhardt A, Spadinger U, Rieder H, Fonatsch C, Hossfeld DK, Harbott J, Schulz AS, Repp R, Sykora KW, Hoelzer D, Bartram CR: Pre-pre-B acute lymphoblastic leukemia: High frequency of alternatively spliced ALL1-AF4 transcripts and absence of minimal residual disease during complete remission. Blood 84:3835, 1994
50. Hoelzer D, Thiel E, Ludwig WD, Löffler H, Büchner T, Freund M, Heil G, Hiddemann W, Maschmeyer G, Völkers B, Aydemir Ü, for the German Adult ALL Study Group: The German multicentre trials for treatment of acute lymphoblastic leukemia in adults. Leukemia 6:175, 1992 (suppl 2)
51. Hoelzer D, Thiel E, Löffler H, Büchner T, Ganser A. Heil G, Kurrle E, Heimpel H, Koch P, Lipp T, Kaboth W, Kuse R, Küchler R, Sodomann H, Maschmeyer G, Freund M, Diedrich H, von Paleske A, Weh J, Kolb H, Müller U, Bross K, Fuhr G, Gassmann W, Gerecke D, Kress M, Busch FW, Nowrousian RM, Schneider W, Aul C, Rühl H, Bartels H, Harms F, Weiss A, Löffler B, Glöckner W, Fülle H, Pralle H, Ho AD, Bonfert B, Emmerich B, Braumann D, Brenner-Serke M, Planker M, Straif K, Meyer P, Greil R, Petsch S, Gög C, Grüneisen A, Vaupel HA, Bodenstein H, Overkamp F, Schlimok G, Augener W, Ohl S, Nowicki L, Raeth U, Zurborn KH, Neiss A, Messerer D: Teniposide (VM-26) and cytosine arabinoside as consolidation therapy in adult high-risk patients with acute lymphoblastic leukemia. Semin Oncol 14:92, 1987 (2 suppl 1)
52. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
53. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163, 1966
54. Rieder H, Ludwig WD, Gassmann W, Maurer J, Janssen JWG, Gökbuget N, Schwartz S, Thiel E, Löffler H, Bartram CR, Hoelzer D, Fonatsch C: Prognostic significance of additional chromosome abnormalities in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia. Br J Haematol 95:678, 1996
55. Buccheri V, Mihaljevic B, Matutes E, Dyer MJS, Mason DY, Catovsky D: mb-1: A new marker for B-lineage lymphoblastic leukemia. Blood 81:853, 1993
56. Griesinger F, Elfers H, Ludwig WD, Falk M, Rieder H, Harbott J. Lampert F, Heinze B, Hoelzer D, Thiel E, Riehm H, Wörmann B, Fonatsch C, Hiddemann W: Detection of HRX-FEL fusion transcripts in pro-B ALL with and without cytogenetic demonstration of t(4;11). Leukemia 8:542, 1994
57. Behm FG, Smith FO, Raimondi SC, Pui CH, Bernstein ID: Human homologue of the rat chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7.1, identifies childhood acute lymphoblastic leukemias with t(4;11)(q21;q23) or t(11;19)(q23;p13) and MLL gene rearrangements. Blood 87:1134, 1996
58. Smith FO, Rauch C, Williams DE, March CJ, Arthur D, Hilden J, Lampkin BC, Buckley JD, Woods WG, Dinndorf PA, Sorensen P, Kersey J, Hammond D, Bernstein ID: The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23. Blood 87:1123, 1996
59. Hoelzer D, Thiel E, Loftier H, Bodenstein H, Plaumann L, Büchner T, Urbanitz D, Koch P, Heimpel H, Engelhardt R, Müller U, Wendt KC, Sodomann H, Rühl H, Herrmann F, Kaboth W, Dietzfelbinger H, Pralle H, Lunschken C, Hellriegel KP, Spors S, Nowrousian RM, Fischer J, Fülle H, Mitrou PS, Pfreundschuh M, Görg C, Emmerich B, Queisser W, Meyer P, Labedzki L, Essers U, König H, Mainzer K, Herrmann R, Messerer D, Zwingers T: Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults. Blood 64:38, 1984
60. Hoelzer D: Aggressive chemotherapy of ALL in elderly patients. Hematol Oncol 11:12, 1993 (suppl 1)
61. Raimondi SC, Frestedt JL, Pui CH, Downing JR, Head DR, Kersey JH, Behm FG: Acute lymphoblastic leukemias with deletion of 11q23 or a novel inversion (11)(p13q23) lack MLL gene rearrangements and have favorable clinical features. Blood 86:1881, 1995